News Image

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Growth Stock with Technical Breakout Potential

By Mill Chart

Last update: May 21, 2025

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines robust fundamentals with a promising chart pattern, making it worth a closer look.

CATALYST PHARMACEUTICALS stock chart

Fundamental Strengths

  • High Growth: CPRX has demonstrated strong earnings growth, with EPS increasing by 112% over the past year. Revenue growth has also been solid at 23.5% annually.
  • Profitability: The company boasts an operating margin of 39.7%, outperforming 99% of its biotechnology peers. Return on equity stands at 22.5%, reflecting efficient capital use.
  • Financial Health: With no debt and a current ratio of 5.2, CPRX maintains a strong balance sheet. Its Altman-Z score of 17.1 indicates low bankruptcy risk.
  • Attractive Valuation: Trading at a P/E of 15.7, CPRX appears undervalued compared to both its industry and the broader market.

Technical Setup

  • Positive Trends: Both short-term and long-term trends are bullish, with the stock trading near the upper end of its 52-week range.
  • Support Levels: Multiple support zones exist between $23.28 and $21.40, providing a cushion against downside risk.
  • Breakout Potential: Resistance sits at $24.84. A move above this level could signal further upside.
  • Volume & Momentum: The stock has shown consistent buying interest, with above-average liquidity supporting price action.

For a deeper dive, review the full fundamental analysis and technical report.

Our Strong Growth Stocks with Good Technical Setup screener lists more stocks meeting these criteria and is updated daily.

Disclaimer

This is not investing advice! The article highlights observations at the time of writing, but you should always conduct your own analysis before making investment decisions.

CATALYST PHARMACEUTICALS INC

NASDAQ:CPRX (6/18/2025, 8:00:00 PM)

After market: 23.7492 +0.94 (+4.12%)

22.81

-0.41 (-1.77%)



Find more stocks in the Stock Screener

CPRX Latest News and Analysis

ChartMill News Image12 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Rare Combination of Growth and Value

CATALYST PHARMACEUTICALS (CPRX) offers strong growth, solid profitability, and an attractive valuation, making it a standout in biotech.

ChartMill News Image15 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for CANSLIM Investors

CATALYST PHARMACEUTICALS (CPRX) meets CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals. A technical uptrend and reasonable valuation add to its appeal.

ChartMill News Image17 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for Growth Investors

CATALYST PHARMACEUTICALS INC (CPRX) meets key growth criteria from Louis Navellier’s strategy, with strong earnings, revenue growth, and solid financial health. A detailed analysis highlights its potential for investors.

Follow ChartMill for more